SwiftPharma BV announced a partnership with the Medicines Patent Pool and the Population Council under Project ELYRA, a collaborative initiative aimed at advancing development pathways and future access for Griffithsin (GRFT)-based products to prevent sexually transmitted infections (STIs), including HIV, HSV, HPV, gonorrhea, syphilis, and chlamydia.